Asha Therapeutics utilizes a unique mito-centric approach to develop treatments for neurodegenerative diseases, including Parkinson's Disease, Alzheimer's Disease, Myalgic Encephalomyelitis, and Chronic Fatigue Syndrome. Asha Therapeutics is advancing a new paradigm of drug discovery by re-engineering cellular machinery toward restoring the powerhouse of the cell.
Partial Data by Infogroup (c) 2024. All rights reserved.